IRIS
AMICOSANTE, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.886
EU - Europa 2.469
AS - Asia 830
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
AF - Africa 5
OC - Oceania 3
Totale 32.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.876
DE - Germania 1.037
UA - Ucraina 387
CN - Cina 349
SG - Singapore 341
IE - Irlanda 254
IT - Italia 188
FR - Francia 162
SE - Svezia 106
FI - Finlandia 92
GB - Regno Unito 88
KR - Corea 85
RU - Federazione Russa 56
PL - Polonia 27
RO - Romania 27
IN - India 17
BE - Belgio 15
JP - Giappone 11
BG - Bulgaria 10
KG - Kirghizistan 9
CA - Canada 8
EU - Europa 8
BR - Brasile 4
VN - Vietnam 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
ES - Italia 3
HK - Hong Kong 3
DM - Dominica 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
IS - Islanda 2
NG - Nigeria 2
NL - Olanda 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BF - Burkina Faso 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
TH - Thailandia 1
TW - Taiwan 1
ZM - Zambia 1
Totale 32.207
Salva come PNG Salva come JPEG
Città #
Woodbridge 9.446
Wilmington 7.870
Houston 7.299
Ann Arbor 714
Fairfield 655
Jacksonville 373
Ashburn 311
Chandler 310
Seattle 277
Singapore 275
Dublin 244
Cambridge 219
Medford 186
Beijing 166
Dearborn 152
New York 92
Lawrence 88
Menlo Park 63
Santa Clara 56
Rome 54
Zhengzhou 53
Guangzhou 29
Milan 29
Mülheim 27
San Diego 27
Kraków 25
Norwalk 20
Boardman 16
Nanjing 15
Brussels 14
Falls Church 14
Moscow 14
Mountain View 14
Palo Alto 13
Hefei 12
University Park 12
San Mateo 11
Shanghai 11
Verona 11
Redwood City 9
Sofia 9
Helsinki 7
Mcallen 7
Nanchang 7
Detroit 6
Pune 6
Auburn Hills 5
Fuzhou 5
Hangzhou 5
Indiana 5
Kunming 5
London 5
Saint Petersburg 5
Anagni 4
San Francisco 4
Toronto 4
Xian 4
Brno 3
Dong Ket 3
Madrid 3
Munich 3
Nanning 3
Nuremberg 3
Quzhou 3
Shaoxing 3
Ahmedabad 2
Anderson 2
Aprilia 2
Auckland 2
Bologna 2
Central 2
Chengdu 2
Chongqing 2
Cormano 2
Creede 2
Forest City 2
Hebei 2
Herzliya 2
Jinan 2
Kalyani 2
Los Angeles 2
Montréal 2
Nova Milanese 2
Nuoro 2
Nürnberg 2
Parma 2
Pilis 2
Prescot 2
Roseau 2
Sacramento 2
Shenyang 2
State College 2
Washington 2
Yellow Springs 2
Aigaleo 1
Anzio 1
Ardabil 1
Augusta 1
Bangkok 1
Bosisio Parini 1
Totale 29.407
Salva come PNG Salva come JPEG
Nome #
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 495
HLA-A, -B and -DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations 467
B-Pred, a structure based B-cell epitopes prediction server 451
Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model 450
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain 446
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 445
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 435
Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy 435
Role of individual's T cell immunome in controlling HIV-1 progression 426
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 420
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 409
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 408
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay 408
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 406
null 405
Amino Acid Mutations in Ebola Virus Glycoprotein of the 2014 epidemic 405
An outbreak of Q fever in Bulgaria 404
Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon. 402
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 401
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 401
Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins 401
Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption 400
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants 399
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy 398
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport 397
Key role of human leukocyte antigen in modulating HIV progression: an overview of the possible applications. 397
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 396
Reactivity to mycobacterial antigens by patients with Lofgren's syndrome as a model of phenotypic susceptibility to disease and disease progression. 394
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 394
Dynamics of the laboratory results in patients with pulmonary tuberculosis. 392
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain 392
Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins 392
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 389
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis 387
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 385
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 385
Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection 384
Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis 379
Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis 378
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study 377
Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients 376
Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction 375
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 372
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 369
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children 367
IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor? 366
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 365
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression 364
Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis 364
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 363
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 362
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 362
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 362
Metal-induced diffuse lung disease 361
Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis 359
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 358
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 358
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 355
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 354
Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding 353
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 349
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 346
Beryllium disease 345
Method of antigenic peptide identification and relative use for the preparation of a vaccine anti HIV-1 344
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 342
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis 342
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 339
Computer-based design of an HLA-haplotype and HIV-clade independent cytotoxic T-lymphocyte assay for monitoring HIV-specific immunity 338
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 337
Major histocompatibility locus genetic markers of beryllium sensitization and disease 335
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 335
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 332
[Mycobacterium tuberculosis. From the gene to the diagnosis] 331
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 331
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 326
Rapid immunological test for the diagnosis and monitoring of tuberculosis infection. 324
Seroprevalence of Ebola virus infection in Bombali district, Sierra Leone 319
[Berylliosis in Italy: a case of "sarcoidosis" under the threshold limit value] 317
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 315
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 308
Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies. 298
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 290
T cell recognition in chronic beryllium disease 290
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 282
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 281
Metodo e test diagnostici basati sull’analisi citofluorimetrica dei linfociti T antigene-specifici. 232
Occurrence of Legionella in showers at recreational facilities 145
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns 100
Current use and acceptability of novel diagnostic tests for active tuberculosis: A worldwide survey|Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial 77
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 38
Totale 32.288
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.611
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.041 0 0 569 775 740 884 739 798 708 739 494 595
2020/20214.677 498 564 497 646 432 490 659 472 112 83 187 37
2021/2022790 30 82 22 59 21 92 43 40 52 59 65 225
2022/2023886 105 57 29 106 70 246 93 42 74 1 43 20
2023/2024299 50 6 17 12 17 105 7 2 21 4 2 56
2024/2025518 80 433 5 0 0 0 0 0 0 0 0 0
Totale 32.288